MedPath

Levofloxacin

These highlights do not include all the information needed to use LEVOFLOXACIN INJECTION safely and effectively. See full prescribing information for LEVOFLOXACIN INJECTION. LEVOFLOXACIN injection, for intravenous use Initial U.S. Approval: 1996

Approved
Approval ID

4d400bf9-988f-42ec-93f1-e71a93a324b2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 10, 2021

Manufacturers
FDA

AuroMedics Pharma LLC

DUNS: 968961354

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levofloxacin

PRODUCT DETAILS

NDC Product Code55150-156
Application NumberANDA202328
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 10, 2021
Generic NameLevofloxacin

INGREDIENTS (4)

LEVOFLOXACINActive
Quantity: 500 mg in 20 mL
Code: 6GNT3Y5LMF
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Levofloxacin

PRODUCT DETAILS

NDC Product Code55150-157
Application NumberANDA202328
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 10, 2021
Generic NameLevofloxacin

INGREDIENTS (4)

LEVOFLOXACINActive
Quantity: 750 mg in 30 mL
Code: 6GNT3Y5LMF
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Levofloxacin - FDA Approval | MedPath